Sat 28 Nov 2009 | 20:26 EST

You are here: Home > Business & Finance > Stocks > Officers and Directors

Do More With Reuters

Partner Services

Affiliate Network

Professional Products

Support (Customer Zone)

Financial Products

About Thomson Reuters

Officers and Directors For Idenix Pharmaceuticals, Inc.

Idenix Pharmaceuticals, Inc. (IDIX.O) (Consolidated Issue listed on NASDAQ Global Market)

sector: Healthcare . industry: Pharmaceuticals - Generic & Specialty · View IDIX on other exchanges

As of 27 Nov 2009

1.84USD

Price Change

-0.08

Percent Change

-4.17%

Analyst Recommendations

Independent Research | Broker Research

Name	Age	Since	Current Position
Fanning, Paul	51	2007	Senior Vice President - Human Resources
Hodgson, Thomas	67	--	Lead Director
Weidenbruch, John	48	2006	Executive Vice President, General Counsel, Secretary
Mayers, Douglas	55	2007	Executive Vice President, Chief Medical Officer
Standring, David	58	2007	Executive Vice President - Biology
Hockmeyer, Wayne	64	2002	Director
Cramb, Charles	62	2003	Director
Pelzer, Robert	55	2003	Director
Pollard-Knight, Denise	49	2003	Director
Thomas-Graham, Pamela	46	2005	Director
Projan, Steven	56	2009	Director
Renaud, Ronald	40	2007	Chief Financial Officer, Treasurer
Sommadossi, Jean-Pierre	53	2000	Chairman of the Board, President, Chief Executive Officer

Find out more about IDIX.O

Insider Trading

Reuters.com: Help and Contact Us | Advertise With Us | Mobile | Newsletters | RSS | Labs | Journalism Handbook | Archive | Site Index | Video Index

Thomson Reuters Corporate: Copyright | Disclaimer | Privacy | Professional Products | Professional Products Support | About Thomson Reuters | Careers

International Editions: Africa | Arabic | Argentina | Brazil | Canada | China | France | Germany | India | Italy | Japan | Latin America | Mexico | Russia | Spain | United Kingdom | United States

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.